NPM1 and acute myeloid leukemia: Here, we investigate CD123 expression in a large number of newly diagnosed AML, focusing on the correlation between CD123 expression and NPM1 mutational status, with the aim to explore whether NPM1mut AML could represent an entity that could particularly benefit from anti-CD123 therapies.